ArticleInfection2026
Correction: Long-term health sequelae and quality of life at least 6 months after infection with SARS-CoV-2: design and rationale of the COVIDOM-study as part of the NAPKON population-based cohort platform (POP).
Abstract readPublished Erratum
In one paragraph
Article in Infection, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum for
Authors and funding
41 authors.
A SchäferInstitute of Clinical Epidemiology and Biometry, University of Würzburg, Julius Maximilian University of Würzburg, Wurzburg, Germany.ORCID http://orcid.org/0000-0003-0494-6090
L KristInstitute of Social Medicine, Epidemiology and Health Economics, Charité - Universitätsmedizin Berlin, Berlin, Germany.
W LiebInstitute of Epidemiology, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany.
F A MontellanoInstitute of Clinical Epidemiology and Biometry, University of Würzburg, Julius Maximilian University of Würzburg, Wurzburg, Germany.
M KohlsInstitute of Clinical Epidemiology and Biometry, University of Würzburg, Julius Maximilian University of Würzburg, Wurzburg, Germany.
K HaasInstitute of Clinical Epidemiology and Biometry, University of Würzburg, Julius Maximilian University of Würzburg, Wurzburg, Germany.
G GelbrichInstitute of Clinical Epidemiology and Biometry, University of Würzburg, Julius Maximilian University of Würzburg, Wurzburg, Germany.
S J Bolay-GehrigInstitute of Clinical Epidemiology and Biometry, University of Würzburg, Julius Maximilian University of Würzburg, Wurzburg, Germany.
C MorbachComprehensive Heart Failure Center, University and University Hospital Würzburg, Wurzburg, Germany.
J P ReeseInstitute of Clinical Epidemiology and Biometry, University of Würzburg, Julius Maximilian University of Würzburg, Wurzburg, Germany.
S StörkComprehensive Heart Failure Center, University and University Hospital Würzburg, Wurzburg, Germany.
J FrickeInstitute of Social Medicine, Epidemiology and Health Economics, Charité - Universitätsmedizin Berlin, Berlin, Germany.
T ZollerDepartment of Infectious Diseases and Respiratory Medicine, Charité - Universitätsmedizin Berlin, Berlin, Germany.
S SchmidtClinical Trial Unit, Clinical Study Center, Berlin Institute of Health, Charité - Universitätsmedizin Berlin, Berlin, Germany.
P TrillerClinical Trial Unit, Clinical Study Center, Berlin Institute of Health, Charité - Universitätsmedizin Berlin, Berlin, Germany.
L KretzlerClinical Trial Unit, Clinical Study Center, Berlin Institute of Health, Charité - Universitätsmedizin Berlin, Berlin, Germany.
M RönnefarthClinical Trial Unit, Clinical Study Center, Berlin Institute of Health, Charité - Universitätsmedizin Berlin, Berlin, Germany.
C Von KalleClinical Trial Unit, Clinical Study Center, Berlin Institute of Health, Charité - Universitätsmedizin Berlin, Berlin, Germany.
S N WillichInstitute of Social Medicine, Epidemiology and Health Economics, Charité - Universitätsmedizin Berlin, Berlin, Germany.
F KurthDepartment of Infectious Diseases and Respiratory Medicine, Charité - Universitätsmedizin Berlin, Berlin, Germany.
F SteinbeisDepartment of Infectious Diseases and Respiratory Medicine, Charité - Universitätsmedizin Berlin, Berlin, Germany.
M WitzenrathDepartment of Infectious Diseases and Respiratory Medicine, Charité - Universitätsmedizin Berlin, Berlin, Germany.
T BahmerDepartment of Internal Medicine I, University Hospital Schleswig-Holstein, Campus Kiel, Arnold-Heller-Straße 3, 24105, Kiel, Germany.
A HermesInstitute of Epidemiology, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany.
M KrawczakInstitute of Medical Informatics and Statistics, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany.
L ReinkeDepartment of Internal Medicine I, University Hospital Schleswig-Holstein, Campus Kiel, Arnold-Heller-Straße 3, 24105, Kiel, Germany.
C MaetzlerDepartment of Neurology, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany.
J FranzenburgInstitute for Laboratory Medicine, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany.
J EnderleInstitute of Epidemiology, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany.
A FlinspachDepartment of Internal Medicine I, University Hospital Schleswig-Holstein, Campus Kiel, Arnold-Heller-Straße 3, 24105, Kiel, Germany.
J VehreschildMedical Department 2, Hematology/Oncology and Infectious Diseases, University Hospital of Frankfurt, Frankfurt, Germany.
M SchonsDepartment I for Internal Medicine, Faculty of Medicine, University Hospital Cologne, University of Cologne, Cologne, Germany.
T IlligHannover Medical School, Hannover Unified Biobank, Hannover, Germany.
G AntonInstitute of Epidemiology, Helmholtz Center Munich, Munich, Germany.
K UngethümInstitute of Clinical Epidemiology and Biometry, University of Würzburg, Julius Maximilian University of Würzburg, Wurzburg, Germany.
B C FinkenbergDepartment of Public Health, District Office Würzburg, Wurzburg, Germany.
M T GehrigDepartment of Public Health, District Office Schweinfurt, Schweinfurt, Germany.
N SavaskanDepartment of Public Health, District Office Berlin-Neukölln, Berlin, Germany.
P U HeuschmannInstitute of Clinical Epidemiology and Biometry, University of Würzburg, Julius Maximilian University of Würzburg, Wurzburg, Germany. epidemiologie-sekretariat@uni-wuerzburg.de.
T KeilInstitute of Clinical Epidemiology and Biometry, University of Würzburg, Julius Maximilian University of Würzburg, Wurzburg, Germany.
S SchreiberDepartment of Internal Medicine I, University Hospital Schleswig-Holstein, Campus Kiel, Arnold-Heller-Straße 3, 24105, Kiel, Germany. s.schreiber@mucosa.de.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Identifiers
PMID
42507325What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.